Enhabit (EHAB) Expected to Announce Earnings on Wednesday

Enhabit (NYSE:EHAB - Get Free Report) is projected to post its quarterly earnings results after the market closes on Wednesday, March 5th. Analysts expect Enhabit to post earnings of $0.07 per share and revenue of $259.11 million for the quarter. Individual interested in participating in the company's earnings conference call can do so using this link.

Enhabit Stock Up 1.1 %

Shares of NYSE:EHAB traded up $0.09 during trading on Friday, hitting $8.37. 482,054 shares of the company were exchanged, compared to its average volume of 266,522. The stock has a market capitalization of $420.88 million, a P/E ratio of -3.61 and a beta of 1.83. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. Enhabit has a 12-month low of $6.85 and a 12-month high of $11.74. The firm's 50 day moving average price is $8.13 and its 200-day moving average price is $7.91.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. Leerink Partners restated a "market perform" rating and set a $8.00 price objective (down previously from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. Jefferies Financial Group upgraded shares of Enhabit from a "hold" rating to a "buy" rating and upped their price target for the company from $8.25 to $9.50 in a research report on Monday, December 9th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $8.75.

Remove Ads

Insider Activity at Enhabit

In other news, Director Stuart M. Mcguigan acquired 15,000 shares of the business's stock in a transaction on Tuesday, December 10th. The stock was bought at an average price of $8.81 per share, for a total transaction of $132,150.00. Following the transaction, the director now owns 46,810 shares in the company, valued at $412,396.10. This represents a 47.15 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Jeffrey Bolton acquired 4,000 shares of the business's stock in a transaction on Thursday, December 12th. The shares were purchased at an average price of $8.69 per share, with a total value of $34,760.00. Following the transaction, the director now owns 98,144 shares in the company, valued at $852,871.36. The trade was a 4.25 % increase in their position. The disclosure for this purchase can be found here. 1.90% of the stock is owned by insiders.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.